Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Quoin Pharmaceuticals Q2 EPS $(6.28) Beats $(7.41) Estimate

Author: Benzinga Newsdesk | August 07, 2025 07:34am
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(6.28) per share which beat the analyst consensus estimate of $(7.41) by 15.25 percent. This is a 54.09 percent increase over losses of $(13.68) per share from the same period last year.

Posted In: QNRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist